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Study Objective. To estimate and compare the prevalence of dementia and depression among adults with and without
developmental disabilities (DDs). Methods. We linked data from several provincial administrative databases to identify persons
with DDs. We matched cases with DD with persons without DD as to sex, age, and place of residence. We estimated the prevalence
of dementia and depression and compared the two groups using the Generalized Estimating Equations (GEEs) technique. Results.
The estimated prevalence of depression and dementia among younger adults (20–54) and older adults (50+) with DD was
signiﬁcantly higher than the estimated rates for the matched non-DD group (Depression: younger adults: RR = 2.96 (95% CI2.59–
3.39); older adults: RR = 2.65 (95% CI1.84–3.81)), (Dementia: younger adults: RR = 4.01 (95% CI2.72–5.92); older adults: RR =
4.80 (95% CI2.48–9.31)). Conclusion. Signiﬁcant disparities exist in mental health between persons with and without DDs.
1.Introduction
Persons with developmental disabilities (DDs) are those who
“have signiﬁcantly greater diﬃculty than most people with
intellectual and adaptive functioning and have had such
diﬃcultiesfromaveryearlyage.Adaptivefunctioningmeans
carrying out everyday activities such as communicating and
interacting with others, managing money, doing household
activities and attending to personal care” [1]. DD is often
used by researchers as a broad term to include a range of
neurologicaldiagnoses.Inthispaper,wereporttheestimated
prevalence of dementia and depression for adults with DDs,
intellectual disability (ID), and autism spectrum disorders
(ASDs).
Although prior research shows that life expectancy for
persons with DDs, and in particular for those with Down
syndrome, has increased signiﬁcantly over the last few
decades [2], signiﬁcant health disparities remain between
personswithandwithoutDDs(e.g.,[3,4]).Ofgreatconcern
are disparities in mental health; a large proportion of
persons with moderate to severe DDs (upwards of 30–60%)
reportedly have mental disorders [5]. Extensive information
exists on the mental health needs and the prevalence of
speciﬁc mental illnesses among persons with DD from
the United States and several European countries (e.g.,
[6–15]). However, the literature on the mental health needs
of persons with DD in Canada remains very limited [16–25].
Most Canadian research has focused on hospitalizations for
mental health or psychiatric disorders [16, 17, 19–21, 23–25]
and has centered on the Canadian province of Ontario
[19–21, 23–25]. Some of these studies focused on a small
number of persons from a selected unit or hospital [22].2 International Journal of Family Medicine
The most recent Canadian study [16], also based on hos-
pitalization records, but nationally, used data administered
by the Canadian Institute of Health Information (CIHI).
This study concluded that, overall, 41.5% of all Canadian
hospitalizations among persons with DD occurred for
psychiatric reasons. Although Canada has an estimated
120,000+individuals aged 15 or older living with DDs [26],
no population-level information exists on the prevalence
and epidemiology of mental illnesses among this population
living in the community or on their mental health needs.
People living with a dual diagnosis of DD and mental
illness have complex health and social needs, therefore
requiring ongoing support for health, housing, education,
and employment. Late diagnosis and inadequate support
could result in signiﬁcant economic cost and further com-
plications both for these individuals and for their families
and caregivers [27]. We need accurate estimations of the
prevalence of mental illnesses in this population, along
with other demographics and health-related information,
to better identify their medical and social support service
needs. To address this lack, we conducted the present study
using linked data from several provincial administrative
databases in Manitoba to (1) estimate the prevalence of
two types of mental illnesses, dementia and depression,
among younger (20–54) and older (55+) adults with DD;
(2) compare the age-speciﬁc prevalence estimates between
persons with DD and a matched comparison group without
DD. We focused on dementia and depression because prior
research yielded high, but inconsistent, prevalence estimates.
Moreover, research indicates that these two illnesses are a
growing source of functional decline, morbidity, and poor
quality of life (e.g., [2, 27]).
Dementia is a mental disorder characterized by a loss
of intellectual abilities of suﬃcient severity to interfere
with social or occupational performance [28]. Although
some studies have examined the risk of dementia among
people with DD, only a few were population-based studies.
Most of these studies—conducted in the USA, UK, Ireland,
and Australia—focused on the prevalence of dementia only
amongsubjectswithID.Thesestudiesproducedinconsistent
results. For example, a state-wide survey in New York State
found an overall prevalence of 3.1% among individuals with
ID aged 40 and older. The prevalence among persons with
ID aged 60 and over was estimated at 6.1% [29]. In Ireland
[30], Tyrrell and colleagues (2001), using DSM-IV criteria
for dementia, estimated age-speciﬁc prevalence at 1.4% for
those aged 40 and under, 5.7% for those aged 40 to 49,
and 30.4% for those aged 50 to 59. A recently published
report on dementia in older adults with ID [31] highlights
the considerable variation found amongst studies in terms of
dementia prevalence.
Depression, another mental health disorder shown to
aﬀect persons with DD at a higher rate than the general pop-
ulation, is a common disorder that presents with depressed
mood, loss of interest or pleasure, feelings of guilt or low
self-worth, disturbed sleep or appetite, low energy, and
poor concentration [32]. National data from the Canadian
Community Health Survey: Mental Health and Well-Being
(CCHS 1.2) estimates the lifetime prevalence of major
depressive episodes among Canadians aged 15+ at 12.2%
[95% CI, 11.7–12.7%] [33]. Using health administrative
data, one report estimated the ﬁve-year treatment prevalence
of depression for the population of Manitoba, Canada, at
18.2% (18.09–18.29). It reported that the highest prevalence
of depression among residents of Manitoba over a ﬁve-year
time period occurred in adults aged 35 to 54 [34].
Although reports of depression prevalence exist for
persons with DD, they provide fairly inconsistent results.
Moreover, most prior studies focus on the risk of depression
among persons with ID only. For example, a study by
Deb and colleagues in South Wales, UK (2001) screened a
group of 90randomly selected adults with ID aged 16 to
64 for various psychiatric illnesses, using the Mini Psychi-
atric Assessment Schedule for Adults with Developmental
Disability (Mini PAS-ADD) and using criteria from the
International Classiﬁcation of Diseases-10th revision (ICD-
10). Using both criteria, the study estimated the prevalence
of depressive disorder at 2.2% [9]. More recently, Bhaumik
and colleagues investigated the psychiatric diagnoses of
2711adults with ID aged 19 and older in Leicestershire
and Rutland, UK [14]. All diagnoses were recorded based
on clinical assessments using ICD-10 criteria. The study
estimated the overall prevalence of depressive syndrome at
4.3%. In contrast to these results, Marston et al. (1997)
used a standard checklist comprising 30symptoms from
ICD-10 diagnostic criteria and the Disability Assessment
Schedule [8]. The checklist was completed with the clients
a n dc a r e g i v e r sf o r8 2p e r s o n sw i t hI Da g e d1 5t o5 8i nt h e
West Midlands, England. Marston estimated the prevalence
of depressive syndrome at 43.9%. As the reviewed literature
makes evident, the majority of prior studies focused on the
risk of depression only among persons with ID and reported
variable estimates. The substantial variations in reported
rates could be due to several factors, including the speciﬁc
type of ID studied, study population characteristics (e.g., age
and sex), depression criteria, and methods of measurement.
Given the existing inconsistencies in the reported esti-
mates and the lack of population-based information on the
prevalence of depression and dementia among persons with
DD in Manitoba, we conducted the present study using
population-based linked administrative data from several
sources to (1) estimate the prevalence of depression and
dementia among younger (20 to 54) and older (55+) adults
with DD living in Manitoba and (2) compare their estimated
rates to those of a matched comparison group without DD.
2. Methods
2.1. Region and Population. Manitoba has a population of
1.17million, making it the 5th largest of Canada’s provinces
and territories. Children under the age of 15 make up 19.6%
of Manitoba’s population, whereas seniors aged 65 and
over represent 14.1% [35]. Manitoba has a relatively large
aboriginal population (12.7%), which has a much higher
reported rate of disability (e.g., [36]). The target population
of our study comprised Manitoba residents of all ages. We
used the December 31, 2000, population count from the
Manitoba population Registry for prevalence estimation.International Journal of Family Medicine 3
2.2. Data Sources. This study analyzed ﬁve ﬁscal years of
data (from April 1, 2000, to March 31, 2005) from multiple
administrative databases contained in the Manitoba Popula-
tion Health Research Data Repository (hereafter, the Repos-
itory). The Manitoba Centre for Health Policy (MCHP)
of the University of Manitoba maintains the Repository,
which contains a comprehensive collection of anonymized
but linkable health and nonhealth administrative databases
covering all Manitoba residents. Researchers have used the
Repositoryextensivelyforpopulation-basedresearchandthe
quality of the Repository’s data has been evaluated as high
based on the completeness of the data sets and the accuracy
of the information recorded [37–41]. The following section
brieﬂy describes the administrative data sets used in the
present study.
2.2.1. Population-Based Registry. The registry contains
demographic information, such as age, sex, and location of
residence, for all Manitoba residents (including those living
in First Nations communities) registered with the provincial
department of health, Manitoba Health (MH), to receive
publicly funded universal health care. Thus, it provides an
accurate number of the population of Manitoba to serve as
the denominator for the calculation of age-speciﬁc rates.
We used information on age, sex, and place of residence for
matching purposes.
2.2.2. Administrative Health Databases. The provincial gov-
ernment originally developed the administrative health
databases in 1970 to administer the universal medical insur-
ance plan. The Repository at MCHP contains anonymized
records of these databases for virtually all contacts with the
provincialhealthcaresystem,includingphysicians,hospitals,
personal care (nursing) homes, and home care, as well as
pharmaceutical prescriptions. All individuals registered in
the provincial health care program are assigned a nine-
digitPersonalHealthIdentiﬁcationNumber(PHIN).MCHP
uses an encrypted, scrambled version of the PHIN as the
consistent nonidentifying research number, which permits
researchers to link data across data ﬁles and track individuals
overtimewhileensuringconﬁdentiality.Thisstudyuseddata
from three health administrative databases. First, we used
the Hospital Abstracts database, which contains information
taken from medical charts created when patients are dis-
charged from hospital. It includes demographic as well as
clinical information relating to inpatient and outpatient ser-
vices received [42]. The clinical information in the database,
which uses the ICD-9-CM (the International Classiﬁcation
of Diseases— 9th Revision—Clinical Modiﬁcation), codes
up to 16 diagnoses and 12 surgical procedures [43]. As of
April 1, 2004, the ICD–10-CA and CCI, the 10th revision
of the ICD coding system, codes up to 25 diagnoses and 20
procedures. This study searched all hospital discharge codes
when looking for a diagnosis.
Second, we used the Physician Claims database,w h i c h
contains information from records of patient contacts with
physicians. This database has the primary purpose of ﬁnan-
cially reimbursing health care providers for services pro-
vided. The clinical information on physician claims includes
only one diagnosis coded using ICD-9-CM [43]. Third,
we used the drug database, which contains prescription
drug claims from the Drug Programs Information Network
(DPIN), an online point-of-sale prescription drug database
forallcommunity-basedpharmaceuticalsdispensedtoMan-
itoba residents since 1994.
2.3. Developmental Disability Case Deﬁnition. Using data
from the Repository, we identiﬁed all persons living with a
DD(i.e.,cases)inManitobaduringtheﬁve-yearstudyperiod
from April 1, 2000, to March 31, 2005. These cases included
those meeting at least one of the following three criteria: (1)
received income assistance for reasons of ID, from Manitoba
Department of Family Services and Consumer Aﬀairs; (2)
received special education funding from Manitoba Depart-
ment of Education for reasons of multiple handicaps, usually
deﬁned as ID plus one or more physical disabilities; (3)
had at least one ICD diagnostic code for ID and/or ASDs
in either the physician claims or the hospital abstracts
database. The ICD diagnostic codes used in this study to
identify cases with ID included 317 (mild mental retardation
(MR)), 318 (moderate, severe, and profound MR), 319
(unspeciﬁed MR), 760 (fetal alcohol spectrum disorders
(FASDs)), and 758 and 759 (chromosomal and congenital
anomalies associated with MR, including Down’s syndrome,
Patau’s and Edward syndromes, Fragile X syndrome, and
Prader Willi syndrome). The ICD–10–CD that we used
included F700–F701; F708–F711; F718–F721; F728–F731;
F738–F739; F780–F781; F788–F791; F798–F799; F840–F841;
F843–F845; F848–F849; P043; Q860–Q862; Q868; Q870–
Q873; Q875; Q878; Q898; Q900–Q902; Q909–Q917; Q930–
Q939; Q992.
2.4. Study Period. We based all analyses presented in this
paperonﬁveﬁscalyearsofdata:fromApril1,2000,toMarch
31, 2005.
2.5. Study Population. The total number of individuals of
all ages who met at least one of our DD criteria was
7,362. Of these, 7,135 persons had at least 365days of
coverage. Of these, we excluded those residing in personal
care homes (PCHs), that is, a nursing home, or having
a Public Trustee postal code. We made this decision for
several reasons. First, we suspected that cases with DDs in
PCHs and those listed with a Public Trustee postal code
would have higher rates of comorbidities, including mental
illnesses, making their health proﬁles quite diﬀerent from
those living independently in their communities. Second,
compared to the general population, those in PCHs or in
other residential facilities have a diﬀerent level of access to
health and social services; therefore, including them might
introduce some bias to our results. Third, we excluded such
cases because, in some cases, it was diﬃcult to match them
according to their place of residence. We also excluded ten
people from the study group because they had no assigned
Income Quintiles (IQ) (An income quintile divides the
population into ﬁve income groups (from lowest to highest
income)with(approximately)20%ofthepopulationineach
group. We derived the income quintiles with data from the4 International Journal of Family Medicine
public-use census ﬁle 2001 developed by Statistics Canada.
We linked the census ﬁle to the Manitoba population from
the Manitoba Population Registry via the corresponding
postal code conversion ﬁles) information attached to them
in the database. This left us with a total of 6,054individuals
who lived for at least one full year between 2000 and 2005
in the community and who met our DD criteria. Of these
6,054, we matched a total of 6,027 by sex, age (year of
birth), and three-digit postal code, using a ratio of 1:2. We
matched for age, since persons with DDs are found to be
a much younger population than the non-DD population.
In addition, research has shown that the prevalence of
some mental illness conditions—for example, dementia—
increases with age [2]. We matched for sex, as research shows
that a higher proportion of persons with DD are males
than females [44]. In addition, the conditions of interest,
depression and dementia, are more commonly found among
females[34,45].Wealsomatchedthetwostudygroupsbased
on place of residence, since research shows that this aﬀects
individuals’ access to health services (e.g., [46, 47]).
We matched a total of 27people on the basis of the same
characteristics, but using a ratio of 1:1. We could not match
the remaining six individuals, so we excluded them from
the analysis. Thus, our DD population comprised a total of
6,048persons with DD living in the community. We based
the analyses presented in this paper on data for those aged
20+ with DD (n = 1,619) and their matched comparison
group (n = 3,231).
2.6. Study Measures
2.6.1. Prevalence of Dementia. We determined a history
of dementia using the ICD diagnostic codes from the
medical records, including both the Physician Claims and
Hospital Abstracts databases, using ﬁve years of data—
2000/2001 to 2004/2005. We considered the presence of
any of the ICD-9-CM codes of 290–292 (organic psychotic
conditions), 294 (other organic psychotic conditions), 331
(cerebral degenerations), or 797 (senility) in either database
an indication of dementia. ICD–10–CA codes included F00,
F01, F02, F03, F04, F05.1, F06.5, F06.6, F06.8, F06.9, F09,
F10–F19, G30, G31.0, G31.1, G31.9, G32.8, G91, G93.7, G94,
and R54.
2.6.2. Prevalence of Depression. We determined a history of
depression via the ICD diagnostic codes from the medical
records, as well as the prescribed medication database, using
the following criteria:
(I) atleastonehospitalizationwithadiagnosisofdepres-
sivedisorder,aﬀectivepsychosis,neuroticdepression,
or adjustment reaction [ICD–9–CM codes 296.2–
296.8, 300.4, 309, 311; ICD–10–CA codes F31, F32,
F33, F341, F38.0, F38.1, F41.2, F43.1, F43.2, F43.8,
F53.0, F93.0];
(II) at least one physician visit with a diagnosis for
depressive disorder, aﬀective psychosis, or adjust-
ment reaction [ICD–9–CM codes 296, 309, or 311];
(III) at least one hospitalization with a diagnosis for anx-
iety disorders [ICD–9–CM code 300; ICD–10–CA
codes F32.0, F34.1, F40, F41, F42, F44, F45.0, F451,
F452, F48, F68.0, F99] and one or more prescriptions
for an antidepressant or mood stabilizer;
(IV) at least one physician visit with a diagnosis for
anxiety disorders [ICD–9–CM code 300] and one or
more prescriptions for an antidepressant or mood
stabilizer.
This operational deﬁnition of depression has been validated
and follows prior health research using MCHP health
administrative data sets [47, 48].
We calculated prevalence estimates in two diﬀerent ways:
(1) as the number of people with the chronic condition of
interest per 100population and (2) as the number of people
with the chronic condition of interest per 1,000person-years
(PYs), to take into consideration years of coverage over the
ﬁve years of the study period. Note that administrative data
do not directly identify people who had a particular disease
of interest; rather, they indicate who used health services for
that particular disease or illness.
2.7. Data Analyses. As mentioned earlier, we calculated the
prevalence of dementia and depression in two diﬀerent
ways. For descriptive analyses, we reported prevalence as the
proportionofthepopulation(%)withdementiaanddepres-
sion. We used Generalized Estimating Equations (GEE; SAS
PROC GENMOD, with repeated subject) to test if the rates
of dementia and depression (calculated as the number of
people with the conditions of interest, that is, depression and
dementia, per 1,000PYs) were statistically higher or lower
than the estimated rates for the matched comparison group.
The GEE is a method of analyzing correlated data, where the
exponent of the estimate indicates the risk ratio (RR) [49].
We used the RR and 95% conﬁdence intervals to determine
the statistical signiﬁcance of the observed diﬀerences in
prevalence estimates. We performed programming and data
analyses using SAS software, version 9.1.
2.8. Ethics. The University of Manitoba Health Research
Ethics Board, the Health Information Privacy Committee
(HIPC) of Manitoba Health, Department of Family Services
and Consumer Aﬀairs and the Manitoba Department of
Education approved this research.
3. Results
Between April 2000 and March 2005, a total of 6,048persons
of all ages lived with DD in Manitoba—64.15% males and
35.85% females. As shown in Table 1, slightly higher than
73% of the population with DD were children under the age
of 20; 1,619 were adults aged 20+. Of these, 1,401 (or 86.5%)
were between the ages of 20 and 54, and 218 (or 13.5%) were
55years of age or older (Table 1). Of the 218individuals with
DD aged 55+, 101 were males and 117 were females.
As shown in Table 2, among persons with DD aged
b e t w e e n2 0a n d5 4( N = 1,401), a total of 73 had a
diagnosis of dementia during the ﬁve-year study period. ThisInternational Journal of Family Medicine 5
Table 1: Distribution of study subjects by age group.
Age group (years) DD population Matched non-DD Total
n % n % n %
0–4 775 12.81 1,548 12.82 2,323 12.82
5–9 1,517 25.08 3,027 25.08 4,544 25.08
10–14 1,316 21.76 2,625 21.75 3,941 21.75
15–19 821 13.57 1,638 13.57 2,459 13.57
20–24 351 5.80 701 5.81 1,052 5.81
25–34 398 6.58 794 6.58 1,192 6.58
35–44 364 6.02 728 6.03 1,092 6.03
45–54 288 4.76 575 4.76 863 4.76
55–64 137 2.27 272 2.25 409 2.26
65+ 81 1.34 161 1.33 242 1.34
Total 6,048 100.00 12,069 100.00 18,117 100.00
Table 2: Dementia prevalence (per 100population), 2000/01–2004/05.
Study population and age groupings Total N Number with dementia Prevalence (95% CI)
DD cohort
20–54Yrs 1,401 73 5.21 (4.05, 6.37)
55+Yrs 218 30 13.76 (9.19, 18.33)
Matched comparison group (no DD)
20–54Yrs 2,798 39 1.39(0.96, 1.83)
55+Yrs 433 15 3.46 (1.74, 5.19)
translatesintoaprevalenceof5.21%(95%CI4.05–6.37).DD
cases aged 55+ had almost triple the prevalence at 13.76%
(95% CI 9.19–18.33). Results of statistical testing using the
GEE technique showed that a signiﬁcantly higher estimated
prevalence of dementia among both younger adults and
older adults with DD than for the matched comparison
groups without DD. As summarized in Table 4,w ee s t i m a t e d
the RR for dementia for the younger adult group at 4.01
(95% CI 2.72–5.92); for the older age group, we estimated
the RR at 4.80 (95% CI 2.48–9.31).
As shown in Table 3, 595 (42.47%) of the DD study
cohort aged 20 to 54 had a diagnosis of depression during
the ﬁve-year study period. Among the older population with
DD, 84 (38.53%) had a diagnosis of depression. Statistical
testing using the GEE technique showed that the estimated
prevalence among both younger adults and older adults
with DD was signiﬁcantly higher than the estimates for the
matched comparison groups without DD. As Table 4 shows,
we estimated the RR for depression at 2.96 (95% CI 2.59–
3.39) for the younger adult group and at 2.65 (95% CI 1.84–
3.81) for the older age group (55+).
4. Discussion
The present study extended previous research on the preva-
lence of mental illnesses among persons with DD by design-
ing a population-based comparative study using the linked
data from several administrative databases, covering the
entire population of a Canadian province. This study was the
ﬁrstattemptinManitobatousearecordlinkagetechniqueto
estimate the prevalence of speciﬁc mental illnesses, including
depression and dementia, at the population level for persons
with DDs. A strength of our study was the use of unique
identiﬁers to link records. This helped us to identify a large
number of persons having DDs and the health conditions of
interestwithoutduplication.Ourmethodology,whichlinked
multiple sources of data, improved our ability to identify DD
caseslivingwithdiagnoseddepressionordementiaanywhere
in Manitoba over the ﬁve-year study period.
Overall, consistent with previous research, our ﬁndings
showed a signiﬁcantly higher prevalence of dementia and
depression in the DD population than in the matched non-
DD population. More speciﬁcally, we found a four times
higher risk of dementia among younger adults with DD than
for the matched non-DD group (RR = 4.01; 95% CI (2.72,
5.92)); the risk was almost ﬁve times higher for the older
age group [RR = 4.8; 95% CI (2.48, 9.31)]. Our estimate
of the prevalence of dementia in the younger age group,
5.21%, aligns with estimates from previous population-
based studies conducted in the USA, Ireland, and the
Netherlands (e.g., [29, 50]). Our estimate of the prevalence
of dementia in the older age group, 13.76%, is lower than
some previously reported estimates (e.g., 30.4% reported by
Tyrrell and colleagues) [23], but it aligns with the 13.1%
estimate for persons with DD aged 60+ reported by Strydom
and colleagues [51].
We found a similar pattern for depression. The risk of
depression among younger adults with DD was almost three
times higher than for the matched non-DD population (RR
= 2.96; 95% CI (2.59, 3.39)). We found a 2.6 times higher6 International Journal of Family Medicine
Table 3: Depression prevalence per 100population, 2000/01–2004/05.
Study population and age group Total N Number with depression Prevalence (95% CI)
DD cohort
20–54Yrs 1,401 595 42.47 (39.88, 45.06)
55+ Yrs 218 84 38.53 (32.07, 44.99)
Matched comparison group
20–54Yrs 2,798 559 19.98 (18.50, 21.46)
55+ Yrs 433 83 19.17 (15.46, 22.88)
Table 4: Age-speciﬁc depression and dementia RRs comparing
those with a DD diagnosis to the matched cohort without a DD
diagnosis.
Risk Ratio 95% Conﬁdence limits
Lower Higher
Dementia
20–54 Yrs 4.01∗ 2.72 5.92
55+Yrs 4.80∗ 2.48 9.31
Depression
20–54Yrs 2.96∗ 2.59 3.39
55+ Yrs 2.65∗ 1.84 3.81
∗P<0.0001
risk of depression among older adults with DD than for
the matched non-DD population (RR = 2.65; 95% CI (1.84,
3.81)). Our estimate of the risk of depression among the
non-DDpopulation,inboththeyounger(19.97%)andolder
age groups (19.18%) in our study, was very similar to the
reported ﬁve-year estimate of depression among the general
population of Manitoba aged 10+ (18.2%) [34].
We estimated the prevalence of depression for the
younger DD population at 42.5%, which agrees with the
reported estimate of 43.9% in a study conducted in the West
Midlands in England [8]. It is, however, much higher than
the reported estimates of 2.2% [9], 4.3% [14], 8% [11], or
11.1% [7] previously reported. The huge variations found
in the prevalence estimates might arise from a number of
factors, including variations in the studied populations. Our
study used administrative data to identify DD cases and
included those with IDs and/or ASDs. Some previous studies
focused on the risk of depression among persons with ID
only [7–9], autism only [10], or a speciﬁc type of ID only
(e.g., Down syndrome) [12]. Other possible contributing
factors include the data source and the type of information
gathered to identify cases with depression. This study used
population-based administrative data to identify cases with
depression. More speciﬁcally, we used clinical diagnoses or
information about prescribed medications to identify those
with indications of depression. This method of identifying
cases diﬀers from the methods used in prior studies.
Some studies used standardized checklists—for example,
the Psychopathology in Autism Checklist [15]—or involved
interviews with clients and their care providers (e.g., [8]).
In addition, some studies only considered cases with severe
depression (e.g., [14]). Our study did not distinguish among
diﬀerent types of depression and included all diagnosed
cases.
Note that, overall, our reported rates of depression and
dementia seem high; this could be due to our reliance on
diagnostic codes rather than the deﬁnitive diagnoses made
by trained specialists for depression or dementia among
this particular population. Thus, we may well have included
many mild forms of depression not normally included in
severe and major depression criteria, as well as cases of
misdiagnosed dementia. Over the last few decades, many
scholars and researchers have noted and discussed the
complexityofdiagnosisandtaxonomyofpsychopathological
conditions in persons with DDs. For example, Verhoeven
and Tuinier (1997) emphasized the atypical presentation
of psychopathological conditions in persons with mental
retardation (MR). They described atypical psychopatho-
logical presentations, for instance—such as self-injurious
behaviour and other challenging behaviours—as symptoms
of depressive disorder [52]. In addition to atypical presenta-
tions of psychopathological conditions by persons with MR,
evidence from factor analytic studies indicates that speciﬁc
psychopathological conditions or symptoms, not classiﬁed
elsewhere, exist among persons with MR [53, 54]. Therefore,
others have questioned the utility of routine diagnostic
criteria for major psychiatric diagnosis among persons with
DD, and in particular for those with MR. In this study,
we used administrative data sources and mainly clinical
diagnosestoestimateprevalenceofdepressionanddementia.
Thus, it is important to note that our prevalence estimates
are reﬂective of “administrative prevalence” rather than the
true prevalence of conditions at the population level. The
true prevalence of the conditions of interest can only be
obtained by screening population using standard diagnostic
criteriaandclinicalassessmentsorbymeansofwell-designed
epidemiological surveys.
Our study has several other limitations relevant to any
interpretation of the results. First, we used administrative
data to identify DD cases. Although we used several admin-
istrative databases, we very likely failed to identify all DD
cases living in Manitoba, since some people with DD may
never have used the existing health services or social support
systemsormaynothavebeendiagnosedashavingaDD.Sec-
ond, we usedonly ﬁveyearsofadministrative data toidentify
bothDDcasesandthementalhealthconditionsofinterest.A
person with dementia or depression might not have had that
particular diagnosis noted in their medical records withinInternational Journal of Family Medicine 7
the ﬁve years of the study. As a result, this study would
not have classiﬁed such a person as having dementia or
depression. Having said that, it is important to note that
MCHP researchers validated the dementia and depression
operational case deﬁnitions based on the health administra-
tive databases against other data sources (e.g., the Canadian
Community Health Surveys) and found that they provide
reliable prevalence estimates at the population level [55].
Third, although we matched the DD cases with non-
DD controls based on age, sex, and place of residence for a
more accurate and fair comparison, we selected our control
group from the general population. This method of selecting
the control group may have introduced some bias, leading
to the higher risk ratios obtained in our study. We know
that those accessing the health care system (using physicians
or hospitals) may have higher rates of comorbidity; they
may also receive more comprehensive medical examinations,
which could increase their rates of diagnosed conditions—
which, in fact, may have aﬀected the rates estimated in this
study.
We want to acknowledge several other limitations of this
study. We based our prevalence estimates on several health
administrative databases, including data from physician
claims. In remote areas of northern Manitoba, nurses (rather
than physicians) deliver a high proportion of primary care;
since administrative databases do not capture those services,
even for mental health issues, this would skew our estimated
rates.
Also, as mentioned earlier in the Methods section, we
excluded persons from the data sets who had DD and resided
in a PCH or were listed with a Public Trustee postal code.
Although we explained this decision, we acknowledge that it
mayhaveaﬀectedourresultsbyexcludingadisproportionate
number of persons with DD in our original sample who had
dementia.
Despite these several acknowledged limitations, the
present study stands as the ﬁrst attempt to use provincial
administrative databases to examine mental health issues
for persons with DD at the population level. Accurate
population-level information on the mental health status
and conditions of persons with DD is needed for planning
and providing services to meet the speciﬁc needs of this
vulnerable population. The signiﬁcant disparities this study
found in rates of depression and dementia between persons
with and without DD should alert health oﬃcials and
authorities to the level of mental health needs of persons
with DD. The existing policies regarding “community living”
and “aging in place” encourage persons with disabilities and
those with DD to access the mainstream health services, even
for mental health problems. Studies which focused on access
to specialized health services, including access to psychiatric
services by persons with DD, remain rare, but these studies
describe ﬁnding a number of barriers [24, 56]. To reduce
disparities in mental health, those involved in planning
and providing services to this population should focus
on the barriers to accessing mental health services. Also,
we must train health care professionals, including family
physicians, to screen and assess mental health conditions and
problems common among persons with DDs. Furthermore,
weneedmorespecializedtrainingformedicalstaﬀ,including
physicians, to assist them with early detection and the
provision of quality care to this population.
Researchers recommend prevention as a strategy for
reducing disparities in health, including mental health,
between persons with and without DD (e.g., [57]). Pre-
ventive strategies should focus on modiﬁable risk factors,
including promotion of physical activity, mental leisure
activities, and social inclusion and participation—as well
as providing meaningful job opportunities and adequate
nutrition.Studiesalsohighlyrecommendearlydiagnosisand
detection of mental illnesses and management of symptoms
and behaviours to minimize further complications [58]. Our
research ﬁndings advocate for an increase in population-
based epidemiological research studies targeting the preva-
lence of mental illnesses and disorders among individuals
with DD. We need such research to better understand the
extent and scope of mental illnesses in this population
and how they vary by age, geography, sex, and diagnostic
categories (e.g., mental retardation, ASDs, FASDs). We also
suggest that future research consider access to health care,
and in particular access to specialized care, as well as
continuity of care.
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